Ovarian function and blood markers study
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 18 and 45 years old (or under 40 for POI group).
- For healthy group: regular periods and normal blood test results for FSH (follicle-stimulating hormone) and AMH (anti-Müllerian hormone).
- For DOR group: two cycles of higher FSH or low AMH levels.
- For POI group: under 40 with two cycles of very high FSH or low AMH.
- You cannot have certain conditions like congenital ovary problems, recent hormone treatments, severe illnesses, or be pregnant or breastfeeding.
- You must agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This study looks at how a blood test called AMH (anti-Müllerian hormone) is used in people being seen for PCOS or POI (early ovarian failure). The goal is to understand whether AMH measurements are useful for care in clinics and fertility treatment settings.
This trial tests whether taking vitamin C can help women whose ovaries are starting to age faster than usual. It may help improve ovarian function, so women with early signs of reduced fertility could benefit.
This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.
This study measures how quickly the heart “recharges” between beats (often shown as QT timing). It compares women with premature ovarian insufficiency to healthy women to understand whether ovarian insufficiency is linked to heart rhythm differences.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.